International Paper Company, et. al. v. Kleen Products LLC, et. al.

|

(U.S., filed February 3, 2017): Arguing that it was improper of the court to use a presumption of classwide antitrust injury based on alleged price increases that occurred in an unrepresentative price index.  Also arguing that the Court should grant review to clarify when presumptions may be applied in favor of class certification.

Court denied cert

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.